Skip to main content
. 2019 Nov 6;13(12):2697–2714. doi: 10.1002/1878-0261.12583

Table 1.

Characteristics of 517 colorectal adenocarcinoma cases according to ITGA5 expression levels in TCGA cohort.

Characteristicsa All cases, ITGA5 expression levels P
n = 517 High expression, n = 258 (49.9%) Low expression, n = 259 (50.1%)
Age
> 68 247 (47.8%) 118 (45.7%) 129 (49.8%) 0.354b
≤ 68 270 (52.2%) 140 (54.3%) 130 (50.2%)
Sex
Men 279 (54.0%) 140 (54.3%) 139 (53.7.8%) 0.892b
Women 238 (46.0%) 118 (45.7%) 120 (46.3%)
Tumor location
Proximal colon 210 (40.6%) 100 (38.8%) 110 (42.5%) 0.644b
Distal colon 211 (40.8%) 107 (41.5%) 104 (40.2%)
Rectum 96 (18.6%) 51 (19.8%) 45 (17.4%)
Local invasion depth
T1/T2 115 (22.2%) 43 (16.7%) 72 (27.8%) 0.002b
T3/T4 402 (77.8%) 215 (83.3%) 187 (72.2%)
Lymph node involvement
N0 302 (58.4%) 138 (53.5%) 164 (63.3%) 0.041b
N1 122 (23.6%) 64 (24.8%) 58 (22.4%)
N2 93 (18.0%) 56 (21.7%) 37 (14.3%)
Distant metastasis
M0 444 (85.9%) 217 (84.1%) 227 (87.6%) 0.258c
M1 73 (14.1%) 41 (15.9%) 32 (12.4%)
Tumor stage
0/I/II 300 (58.0%) 140 (54.3%) 160 (61.8%) 0.084b
III/IV 217 (42.0%) 118 (45.7%) 99 (38.2%)
Lymphatic invasion
Yes 193 (37.3%) 105 (40.7%) 88 (34.0%) 0.114b
No 324 (62.7%) 153 (59.3%) 171 (66.0%)
a

Percentages in all cases or in the corresponding subgroups (high expression or low expression) are given in the brackets. bχ2 test. cFisher’s exact test.